Skip to main content
Top

Pathology & Oncology Research

Issue 4/2003

Content (9 Articles)

Review

Viral hepatitis: New data on hepatitis C infection

Erzsébet Szabó, Gabor Lotz, Csilla Páska, András Kiss, Zsuzsa Schaff

Article

HCV and HGV infection in Hodgkin’s disease

Katalin Keresztes, Maria Takács, Margit Horányi, Zsófia Miltényi, Árpád Illés

Article

Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer

Mansour A-Moundhri, V. Nirmala, K. Al-Mawaly, S. Ganguly, I. Burney, A. Rizvi, C. Grant

Article

Pseudohyperplastic prostatic adenocarcinoma in transurethral resections of the prostate

Julián Arista-Nasr, Braulio Martinez-Benitez, Samuel Valdes, Mercedes Hernández, Leticia Bornstein-Quevedo

Article

hMLHl and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients

Enikó Kámory, Orsolya Kolacsek, Szabolcs Ottó, Orsolya Csuka

Case Report

Synovial sarcoma: A rare tumor of larynx

Bilge Bilgic, Özgür Mete, A Setter Öztürk, Misten Demiryont, Nesil Keles, Mert Basaran

Case Report

Renal tumor causing haematuria and sepsis

Attila Szendrói, András Rusz, Eszter Székely, Péter Riesz, Zsolt Kelemen

Case Report

Giant cell fibroblastoma in a 3-year-old boy

Roberto Vargas-Gonzalez, Araceli Solis-Coria

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine